Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Bausch Health Companies Inc
  6. Summary
       CA91911K1021

BAUSCH HEALTH COMPANIES INC

 SummaryChartsNewsRatingsCalendarCompany 
Company
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic... 
Sector
Pharmaceuticals
Calendar
10/04 | 11:00amPresentation
More about the company
Ratings of Bausch Health Companies Inc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BAUSCH HEALTH COMPANIES INC
09/21Toronto shares jump as Trudeau win lifts stimulus hopes
RE
09/13BAUSCH HEALTH : Files Confidentially For IPOs of Eye Care Business and Medical Aesthetics ..
MT
09/13BAUSCH HEALTH : Update regarding the B+L Separation and the Solta IPO (Form 8-K)
PU
09/13BAUSCH HEALTH COMPANIES INC. : Other Events (form 8-K)
AQ
09/09Bausch to pay $300 million in antitrust suit over diabetes drug
RE
09/08CIPHER PHARMACEUTICALS BRIEF : Announced Renewal of Normal Course Issuer Bid
MT
09/03BAUSCH HEALTH : Salix Will Share RELISTOR (Methylnaltrexone Bromide) Data At PAINWeek 2021
AQ
09/02BAUSCH HEALTH : Says Salix Will Share Relistor (Methylnaltrexone Bromide) Data At PAINWeek..
MT
08/11SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausc..
PR
08/06INSIDER TRENDS : 90-Day Buying Trend Extended with Insider Purchase of Bausch Health Compa..
MT
08/05BAUSCH HEALTH : Moody's Affirms Ratings on Bausch Health After Announcement of IPO Plan fo..
MT
08/04BAUSCH HEALTH : RBC Capital Keeps Outperform, US$41 TP on Bausch Health After Q2 Results
MT
08/04BAUSCH HEALTH : Barclays Adjusts Bausch Health's Price Target to $31 From $35, Reiterates ..
MT
08/04BAUSCH HEALTH BRIEF : Says Health Canada Approves ARAZLO ARAZLO (Tazarotene) Lotion, 0.045..
MT
08/04BAUSCH HEALTH : Health Canada Approves ARAZLO™ (Tazarotene) Lotion, 0.045%, First Su..
AQ
More news
News in other languages on BAUSCH HEALTH COMPANIES INC
04/29EN DIRECT DES MARCHESá : Total, STMicro, Airbus, Valneva, Unibail, Apple, Facebook, Logite..
04/29STOCK MARKET PARIS : Pour la Fed, il est urgent d'attendre
03/04UPDATE : Winst Pharming gedrukt door dollarkoers
03/04Winst Pharming gedrukt door dollarkoers
2020Behält Warren Buffett am Ende doch recht?
More news
Analyst Recommendations on BAUSCH HEALTH COMPANIES INC
More recommendations
Chart BAUSCH HEALTH COMPANIES INC
Duration : Period :
Bausch Health Companies Inc Technical Analysis Chart | CA91911K1021 | MarketScreener
Managers and Directors
Joseph C. Papa Chairman & Chief Executive Officer
Thomas J. Appio President & Co-Head-Bausch Lomb International
Sam Eldessouky CFO, Chief Accounting Officer, SVP & Controller
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BAUSCH HEALTH COMPANIES INC23.86%10 122
JOHNSON & JOHNSON4.54%433 122
ROCHE HOLDING AG9.82%321 584
PFIZER, INC.20.08%246 246
NOVO NORDISK A/S52.07%234 070
ELI LILLY AND COMPANY36.32%208 668